Page last updated: 2024-11-13

leukotriene c4 monomethyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

leukotriene C4 monomethyl ester: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

leukotriene C4 methyl ester : The methyl ester of leukotriene C4, the esterified acid group being the one forming position 1 of the icosatetraenyl chain. Leukotriene C4 methyl ester is a more lipid-soluble form of leukotriene C4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID101070933
CHEBI ID138115
MeSH IDM0126927

Synonyms (17)

Synonym
leukotriene c4 monomethyl ester
leukotriene c4 methyl ester
l-gamma-glutamyl-s-[(5s,6r,7e,9e,11z,14z)-5-hydroxy-1-methoxy-1-oxoicosa-7,9,11,14-tetraen-6-yl]-l-cysteinylglycine
73958-10-8
ltc4, methyl ester
(2s)-2-amino-5-{[(2r)-1-[(carboxymethyl)amino]-3-{[(5s,6r,7e,9e,11z,14z)-5-hydroxy-1-methoxy-1-oxoicosa-7,9,11,14-tetraen-6-yl]sulfanyl}-1-oxopropan-2-yl]amino}-5-oxopentanoic acid
CHEBI:138115
n-methyl-ltc4
ltc4 me
glycine, n-(n-l-gamma-glutamyl-s-(1-(1-hydroxy-5-methoxy-5-oxopentyl)-2,4,6,9-pentadecatetraenyl)-l-cysteinyl)-, (r-(r*,s*-(e,e,z,z)))-
n-methyl-leukotriene c4
leukotriene c methyl ester
n5-((r)-1-((carboxymethyl)amino)-3-(((5s,6r,7e,9e,11z,14z)-5-hydroxy-1-methoxy-1-oxoicosa-7,9,11,14-tetraen-6-yl)thio)-1-oxopropan-2-yl)-l-glutamine
(2s)-2-amino-5-[[(2r)-1-(carboxymethylamino)-3-[(5s,6r,7e,9e,11z,14z)-5-hydroxy-1-methoxy-1-oxoicosa-7,9,11,14-tetraen-6-yl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
l-gamma-glutamyl-s-[(1r,2e,4e,6z,9z)-1-[(1s)-1-hydroxy-5-methoxy-5-oxopentyl]-2,4,6,9-pentadecatetraen-1-yl]-l-cysteinylglycine
DTXSID901104248
AKOS040755941

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In this study, the dose-response curves of N-methyl LTC4 (NMLTC4), the nonmetabolizable LTC4 analogue, and the peptidoleukotrienes (LTC4, LTD4, and LTE4) were obtained in the absence and presence of the leukotriene antagonist Ro 23-3544 in cannulated frogs."( Cardiovascular effects of N-methyl leukotriene C4, a nonmetabolizable leukotriene C4 analogue, and the antagonism of leukotriene-induced hypotension by Ro 23-3544, in the American bullfrog, Rana catesbeiana.
Herman, CA; Sun, J, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
leukotrieneAny icosanoid from that family of C20 polyunsaturated fatty acids and their derivatives generated by leukocytes from arachidonic acid, each member having four double bonds of which three are conjugated.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]